Back
Actinium Pharmaceuticals, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
43
ATNM
Actinium Pharmaceuticals, Inc.
Last Price:
$1.58
Seasonality Move:
102.85%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is moderately bullish and ATNM is experiencing slight buying pressure.
Actinium Pharmaceuticals, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.59 | Sell |
| 20-day SMA: | 1.49 | Buy |
| 50-day SMA: | 1.44 | Buy |
| 200-day SMA: | 1.52 | Buy |
| 8-day EMA: | 1.58 | Buy |
| 20-day EMA: | 1.51 | Buy |
| 50-day EMA: | 1.48 | Buy |
| 200-day EMA: | 1.69 | Sell |
Actinium Pharmaceuticals, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.06 | Buy |
| Relative Strength Index (14 RSI): | 56.63 | Buy |
| Chaikin Money Flow: | 17975 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.36 - 1.56) | Buy |
| Bollinger Bands (100): | (1.41 - 1.67) | Buy |
Actinium Pharmaceuticals, Inc. Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Actinium Pharmaceuticals, Inc. Stock
Is Actinium Pharmaceuticals, Inc. Stock a Buy?
-
Actinium Pharmaceuticals, Inc. share price is 1.59 while ATNM 8-day simple moving average is 1.59, which is a Sell signal.
-
The stock price of ATNM is 1.59 while Actinium Pharmaceuticals, Inc. 20-day SMA is 1.49, which makes it a Buy.
-
Actinium Pharmaceuticals, Inc. 50-day simple moving average is 1.44 while ATNM share price is 1.59, making it a Buy technically.
-
ATNM stock price is 1.59 and Actinium Pharmaceuticals, Inc. 200-day simple moving average is 1.52, creating a Buy signal.
ATNM Technical Analysis vs Fundamental Analysis
Sell
43
Actinium Pharmaceuticals, Inc. (ATNM)
is a Sell
Is Actinium Pharmaceuticals, Inc. a Buy or a Sell?
-
Actinium Pharmaceuticals, Inc. stock is rated a SellThe current Actinium Pharmaceuticals, Inc. [ATNM] share price is $1.59. The Score for ATNM is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
Actinium Pharmaceuticals, Inc. Stock Info
Market Cap:
49.6M
Price in USD:
1.59
Share Volume:
53.9K
Actinium Pharmaceuticals, Inc. 52-Week Range
52-Week High:
2.41
52-Week Low:
1.03
Sell
43
Actinium Pharmaceuticals, Inc. (ATNM)
is a Sell
Actinium Pharmaceuticals, Inc. Share Price Forecast
-
What is the Actinium Pharmaceuticals, Inc. stock price today?The Actinium Pharmaceuticals, Inc. stock price is 1.59 USD today.
-
Will ATNM stock go up or go down?Actinium Pharmaceuticals, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Actinium Pharmaceuticals, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Actinium Pharmaceuticals, Inc. is overvalued.
Is Actinium Pharmaceuticals, Inc. Stock a Buy?
-
Actinium Pharmaceuticals, Inc. share price is 1.59 while ATNM 8-day exponential moving average is 1.58, which is a Buy signal.
-
The stock price of ATNM is 1.59 while Actinium Pharmaceuticals, Inc. 20-day EMA is 1.51, which makes it a Buy.
-
Actinium Pharmaceuticals, Inc. 50-day exponential moving average is 1.48 while ATNM share price is 1.59, making it a Buy technically.
-
ATNM stock price is 1.59 and Actinium Pharmaceuticals, Inc. 200-day simple moving average is 1.69, creating a Sell signal.
Fundamental Analysis of Actinium Pharmaceuticals, Inc.
Is Actinium Pharmaceuticals, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.35 per share, and an increase next year of $0.34 per share.
Technical Analysis of Actinium Pharmaceuticals, Inc.
Should I short Actinium Pharmaceuticals, Inc. stock?
-
ATNM Moving Average Covergence Divergence (MACD) indicator is 0.06, suggesting Actinium Pharmaceuticals, Inc. is a Buy
-
Actinium Pharmaceuticals, Inc. Relative Strength Index (RSI) is 56.63, which suggest Actinium Pharmaceuticals, Inc. is overbought
-
The Bollinger Bands (25) for Actinium Pharmaceuticals, Inc. is (1.36 - 1.56), which suggest Actinium Pharmaceuticals, Inc. is a Buy
-
The Bollinger Bands (100) for Actinium Pharmaceuticals, Inc. is (1.41 - 1.67), which suggest Actinium Pharmaceuticals, Inc. is a Buy
* Actinium Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.